| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $1.30B | $1.22B | $1.26B |
| YoY Revenue Growth % | +6.6% | -3.4% | — |
| Gross Profit | $635.9M | $592.8M | — |
| Gross Margin % | 49.0% | 48.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $261.4M | $241.4M | $271.1M |
| Operating Margin % | 20.1% | 19.8% | 21.5% |
| Net Income (GAAP) | $209.7M | $195.5M | $219.9M |
| EBITDA (Normalized) | $297.7M | $275.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $251.1M | $242.0M | $254.6M |
| Capital Expenditures (CapEx) | $45.4M | $42.3M | — |
| Free Cash Flow (FCF) | $205.8M | $199.7M | $254.6M |
| FCF Margin % | 15.9% | 16.4% | 20.2% |
| Return on Invested Capital (ROIC %) | 48.6% | 45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $424.6M | $423.8M | — |